Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.53M | -24.83M | -23.42M | -6.61M | -18.96M |
| Total Depreciation and Amortization | 7.68M | 6.00M | 6.11M | 6.04M | 6.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.73M | 9.16M | 10.87M | 9.29M | 21.25M |
| Change in Net Operating Assets | -15.63M | 16.76M | -71.71M | 2.38M | -38.52M |
| Cash from Operations | -23.76M | 7.10M | -78.14M | 11.11M | -30.17M |
| Capital Expenditure | -3.86M | -5.20M | -4.98M | -6.05M | -6.83M |
| Sale of Property, Plant, and Equipment | 0.00 | 8.00K | 0.00 | 3.00K | 0.00 |
| Cash Acquisitions | 0.00 | -55.57M | 0.00 | 3.78M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.66M | 71.70M | 16.13M | 21.36M | 60.23M |
| Cash from Investing | 50.80M | 10.94M | 11.15M | 19.08M | 53.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -88.00K | -564.00K | -88.00K | -88.00K | -88.00K |
| Issuance of Common Stock | 2.00K | 9.00K | 1.00K | -- | -- |
| Repurchase of Common Stock | -24.14M | -44.28M | -447.00K | -357.00K | -2.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.23M | -44.83M | -534.00K | -445.00K | -2.64M |
| Foreign Exchange rate Adjustments | 88.00K | 3.00K | 75.00K | 15.00K | 4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.91M | -26.79M | -67.45M | 29.76M | 20.60M |